Michael Williams is Chief Technology Officer of Synecor, LLC, a business generator of new medical device companies based in the Research Triangle Park, N.C., Santa Rosa, California, and Silicon Valley, California. Synecor has significant academic, scientific, physician, venture capital, corporate, and investment banking partnerships and is focusing its efforts on the identification and development of proprietary, transformational technologies with extraordinary market potential in the life sciences field. Prior to joining Synecor, Mr. Williams was Vice President of Science and Technology at Medtronic AVE. Mr. Williams led the research and development of multiple new technology frontiers including vascular brachytherapy, stent based controlled release drug delivery, photodynamic therapy, gene therapy, tissue engineering, and neurovascular interventions. Mr. Williams founded and was the VP and General Manager of the Neurovascular Technologies Division of Medtronic AVE that was responsible for bringing to market the worlds first neurovascular stent and delivery system. While at Medtronic Mr. Williams was also responsible for all of the vascular division’s pre-clinical, biological and materials research. Before joining AVE Mr. Williams held senior management and engineering positions at Microvena Corporation, Guidant's Advanced Cardiovascular Systems and Baxter Healthcare's Pharmaseal Division. Educated at California Polytechnic State University, San Luis Obispo Mr. Williams holds over 60 issued and pending patents, has coauthored 6 technical papers, abstracts, and a book chapter and has been an invited speaker at various scientific, technical, and clinical conferences.